Skip to main content
Erschienen in: Diabetology International 2/2019

21.08.2018 | Original Article

Changes in insulin requirements during pregnancy in Japanese women with type 1 diabetes

verfasst von: Misa Kambara, Keiko Yanagisawa, Sayoko Tanaka, Tomoko Suzuki, Tetsuya Babazono

Erschienen in: Diabetology International | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

Aims

We investigated the changes in insulin requirements, and other relevant factors, in pregnant Japanese women with type 1 diabetes.

Methods

This retrospective observational study was conducted on 77 singleton pregnant women with type 1 diabetes, treated with multiple daily injections of insulin. We examined changes in daily insulin dose during pregnancy and defined the increased insulin doses as the ratio of maximum dose to the pre-pregnancy dose. The relationship between the increased insulin doses and maternal features or pregnancy outcomes was investigated.

Results

The insulin dose gradually increased during pregnancy, reaching a maximum dose that was 1.6 times of that prior to pregnancy, at 35 weeks of gestation. A negative significant correlation was observed between the insulin dose increases and duration of diabetes (p = 0.008). Greater increases in insulin doses were noted in women with multiparity, compared to nulliparity (p = 0.047). Multiple regression analyses revealed that shorter duration of diabetes was independently associated with the increases in insulin dose during pregnancy.

Conclusions

Women with a longer duration of diabetes required smaller increases in insulin dose during pregnancy, suggesting that long diabetic duration may decrease placental function. Further investigations are needed to clarify the mechanisms that the duration of diabetes influences on insulin requirement during pregnancy.
Literatur
1.
Zurück zum Zitat Ryan EA, Enns L. Role of gestational hormones in the induction of insulin resistance. J Clin Endorinol Metab. 1988;67:341–7.CrossRef Ryan EA, Enns L. Role of gestational hormones in the induction of insulin resistance. J Clin Endorinol Metab. 1988;67:341–7.CrossRef
2.
Zurück zum Zitat Richardson AC, Carpenter MW. Inflammatory mediators in gestational diabetes mellitus. Obstet Gynecol Clin North Am. 2007;34:213–24.CrossRefPubMed Richardson AC, Carpenter MW. Inflammatory mediators in gestational diabetes mellitus. Obstet Gynecol Clin North Am. 2007;34:213–24.CrossRefPubMed
3.
Zurück zum Zitat Langer O, Conway DL. Level of glycemia and perinatal outcome in pregestational diabetes. J Matern Fetal Med. 2000;9:35–41.PubMed Langer O, Conway DL. Level of glycemia and perinatal outcome in pregestational diabetes. J Matern Fetal Med. 2000;9:35–41.PubMed
5.
Zurück zum Zitat Omori Y, Minei S, Tetsuo T, Nemoto K, Shimizu M, Sanaka M. A comparison of pregnancy in IDDM and NIDDM mothers. A comparison of pregnancy in IDDM and NIDDM mothers. Diabetes Res Clin Pract. 1994;24(Suppl):S273–8.CrossRefPubMed Omori Y, Minei S, Tetsuo T, Nemoto K, Shimizu M, Sanaka M. A comparison of pregnancy in IDDM and NIDDM mothers. A comparison of pregnancy in IDDM and NIDDM mothers. Diabetes Res Clin Pract. 1994;24(Suppl):S273–8.CrossRefPubMed
6.
Zurück zum Zitat The committee of the Japan Diabetes Society on the diagnostic criteria of diabetes mellitus, Seino Y, Nanjo K, Tajima N, Kadowaki T, Kashiwagi A, Araki E, Ito C, Inagaki N, Iwamoto Y, Kasauga M, Hanafusa T, Haneda M, Ueki K. Report of the committee on the classification and diagnostic criteria of diabetes mellitus. Diabetol Int. 2010;1:2–20.CrossRef The committee of the Japan Diabetes Society on the diagnostic criteria of diabetes mellitus, Seino Y, Nanjo K, Tajima N, Kadowaki T, Kashiwagi A, Araki E, Ito C, Inagaki N, Iwamoto Y, Kasauga M, Hanafusa T, Haneda M, Ueki K. Report of the committee on the classification and diagnostic criteria of diabetes mellitus. Diabetol Int. 2010;1:2–20.CrossRef
7.
Zurück zum Zitat Kashiwagi A, Kasuga M, Araki E, Oka Y, Hanafusa T, Ito H, Tominaga M, Oikawa S, Noda M, Kawamura T, Sanke T, Namba M, Hashiramoto M, Sasahara T, Nishio Y, Kuwa K, Ueki K, Takei I, Umemoto M, Murakami M, Yamakado M, Yatomi Y, Ohashi H, Committee on the Standardization of Diabetes Mellitus-Related Laboratory Testing of Japan Diabetes Society. International clinical harmonization of glycated hemoglobin in Japan: from Japan Diabetes Society to National Glycohemoglobin Standardization Program values. J Diabetes Invest. 2012;3:39–40.CrossRef Kashiwagi A, Kasuga M, Araki E, Oka Y, Hanafusa T, Ito H, Tominaga M, Oikawa S, Noda M, Kawamura T, Sanke T, Namba M, Hashiramoto M, Sasahara T, Nishio Y, Kuwa K, Ueki K, Takei I, Umemoto M, Murakami M, Yamakado M, Yatomi Y, Ohashi H, Committee on the Standardization of Diabetes Mellitus-Related Laboratory Testing of Japan Diabetes Society. International clinical harmonization of glycated hemoglobin in Japan: from Japan Diabetes Society to National Glycohemoglobin Standardization Program values. J Diabetes Invest. 2012;3:39–40.CrossRef
8.
Zurück zum Zitat Catalano PM, Tyzbir ED, Roman NM, Amini SB, Sims EAH. Longitudinal changes in insulin release and insulin resistance in nonobese pregnant women. Am J Obstet Gynecol. 1991;165:1667–72.CrossRefPubMed Catalano PM, Tyzbir ED, Roman NM, Amini SB, Sims EAH. Longitudinal changes in insulin release and insulin resistance in nonobese pregnant women. Am J Obstet Gynecol. 1991;165:1667–72.CrossRefPubMed
9.
Zurück zum Zitat Phelps RL, Metzger BE, Freinkel N. Carbohydrate metabolism in pregnancy. Am J Obstet Gynecol. 1981;140:730–6.CrossRefPubMed Phelps RL, Metzger BE, Freinkel N. Carbohydrate metabolism in pregnancy. Am J Obstet Gynecol. 1981;140:730–6.CrossRefPubMed
10.
Zurück zum Zitat Garcia-Patterson A, Gich I, Amini SB, Catalano PM, de Leiva A, Corcoy R. Insulin requirements throughout pregnancy in women with type 1 diabetes mellitus: three changes of direction. Diabetologia. 2010;53:446–51.CrossRefPubMed Garcia-Patterson A, Gich I, Amini SB, Catalano PM, de Leiva A, Corcoy R. Insulin requirements throughout pregnancy in women with type 1 diabetes mellitus: three changes of direction. Diabetologia. 2010;53:446–51.CrossRefPubMed
11.
Zurück zum Zitat Langer O, Anyaegbunam A, Brustman L, Guidetti D, Levy J, Mazze R. Pregestational diabetes: insulin requirements throughout pregnancy. Am J Obstet Gynecol. 1988;159:616–21.CrossRefPubMed Langer O, Anyaegbunam A, Brustman L, Guidetti D, Levy J, Mazze R. Pregestational diabetes: insulin requirements throughout pregnancy. Am J Obstet Gynecol. 1988;159:616–21.CrossRefPubMed
12.
Zurück zum Zitat Callesen NF, Ringholm L, Stage E, Damm P, Mathiesen ER. Insulin requirements in type 1 diabetic pregnancy. Do twin pregnant women require twice as much insulin as singleton pregnant women? Diabetes Care. 2012;35:1246–8.CrossRefPubMedPubMedCentral Callesen NF, Ringholm L, Stage E, Damm P, Mathiesen ER. Insulin requirements in type 1 diabetic pregnancy. Do twin pregnant women require twice as much insulin as singleton pregnant women? Diabetes Care. 2012;35:1246–8.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Persson B, Swahn ML, Hjertberg R, Hanson U, Nord E, Nordlander E, Hansson LO. Insulin lispro therapy in pregnancies complicated by type 1 diabetes mellitus. Diabetes Res Clin Pract. 2002;58:115–21.CrossRefPubMed Persson B, Swahn ML, Hjertberg R, Hanson U, Nord E, Nordlander E, Hansson LO. Insulin lispro therapy in pregnancies complicated by type 1 diabetes mellitus. Diabetes Res Clin Pract. 2002;58:115–21.CrossRefPubMed
14.
Zurück zum Zitat Durnwald CP, Landon MB. A comparison of lispro and regular insulin for the management of type 1 and type 2 diabetes in pregnancy. J Matern Fetal Neonatal Med. 2008;21:309–13.CrossRefPubMed Durnwald CP, Landon MB. A comparison of lispro and regular insulin for the management of type 1 and type 2 diabetes in pregnancy. J Matern Fetal Neonatal Med. 2008;21:309–13.CrossRefPubMed
15.
Zurück zum Zitat Mathiesen ER, Kinsley B, Amiel SA, Heller S, McCance D, Duran S, Bellaire S, Raben A. Insulin aspart pregnancy study group. Maternal glycemic control and hypoglycemia in type 1 diabetic pregnancy. Diabetes Care. 2007;30:771–6.CrossRefPubMed Mathiesen ER, Kinsley B, Amiel SA, Heller S, McCance D, Duran S, Bellaire S, Raben A. Insulin aspart pregnancy study group. Maternal glycemic control and hypoglycemia in type 1 diabetic pregnancy. Diabetes Care. 2007;30:771–6.CrossRefPubMed
16.
Zurück zum Zitat Mathiesen ER, Hod M, Ivanisevic M, Garcia SD, Brondsted L, Jovanovic L, Damm P. McCance DR, detemir in pregnancy study group. Maternal efficacy and safety outcomes in a randomized, controlled trial comparing insulin detemir with NPH insulin in 310 pregnant women with type 1 diabetes. Diabetes Care. 2012;35:2012–7.CrossRefPubMedPubMedCentral Mathiesen ER, Hod M, Ivanisevic M, Garcia SD, Brondsted L, Jovanovic L, Damm P. McCance DR, detemir in pregnancy study group. Maternal efficacy and safety outcomes in a randomized, controlled trial comparing insulin detemir with NPH insulin in 310 pregnant women with type 1 diabetes. Diabetes Care. 2012;35:2012–7.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Jovanovic L, Knopp RH, Brown Z, Conley MR, Park E, Mills JL, Metzger BE, Aarons JH, Holmes LB. Simpson JL, the national institute of child health and human development diabetes in early pregnancy study group. Declining insulin requirement in the late first trimester of diabetic pregnancy. Diabetes Care. 2001;24:1130–6.CrossRefPubMed Jovanovic L, Knopp RH, Brown Z, Conley MR, Park E, Mills JL, Metzger BE, Aarons JH, Holmes LB. Simpson JL, the national institute of child health and human development diabetes in early pregnancy study group. Declining insulin requirement in the late first trimester of diabetic pregnancy. Diabetes Care. 2001;24:1130–6.CrossRefPubMed
18.
Zurück zum Zitat Steel JM, Johnstone FD, Hume R, Mao JH. Insulin requirements during pregnancy in women with type 1 diabetes. Obstet Gynecol. 1994;83:253–8.PubMed Steel JM, Johnstone FD, Hume R, Mao JH. Insulin requirements during pregnancy in women with type 1 diabetes. Obstet Gynecol. 1994;83:253–8.PubMed
19.
Zurück zum Zitat McManus RM, Ryan EA. Insulin requirements in insulin-dependent and insulin-requiring GDM women during final month of pregnancy. Diabetes Care. 1992;15:1323–7.CrossRefPubMed McManus RM, Ryan EA. Insulin requirements in insulin-dependent and insulin-requiring GDM women during final month of pregnancy. Diabetes Care. 1992;15:1323–7.CrossRefPubMed
20.
Zurück zum Zitat Huynh J, Dawson D, Roberts D, Bentley-Lewis R. A systematic review of placental pathology in maternal diabetes mellitus. Placenta. 2015;36:101–14.CrossRefPubMed Huynh J, Dawson D, Roberts D, Bentley-Lewis R. A systematic review of placental pathology in maternal diabetes mellitus. Placenta. 2015;36:101–14.CrossRefPubMed
22.
Zurück zum Zitat Lindström T, Frystyk J, Hedman CA, Flyvbjerg A, Arnqvist HJ. Elevated circulating adiponectin in type 1 diabetes is associated with long diabetes duration. Clin Endocrinol (Oxf). 2006;65:776–82.CrossRef Lindström T, Frystyk J, Hedman CA, Flyvbjerg A, Arnqvist HJ. Elevated circulating adiponectin in type 1 diabetes is associated with long diabetes duration. Clin Endocrinol (Oxf). 2006;65:776–82.CrossRef
23.
Zurück zum Zitat Sivan E, Boden G. Free fatty acids, insulin resistance, and pregnancy. Curr Diab Rep. 2003;3:319–22.CrossRefPubMed Sivan E, Boden G. Free fatty acids, insulin resistance, and pregnancy. Curr Diab Rep. 2003;3:319–22.CrossRefPubMed
25.
26.
Zurück zum Zitat Retnakaran R, Kramer CK, Ye C, Kew S, Hanley AJ, Connelly PW, Sermer M, Zinman B. Fetal sex and maternal risk of gestational diabetes mellitus: the impact of having a boy. Diabetes Care. 2015;38:844–51.CrossRefPubMed Retnakaran R, Kramer CK, Ye C, Kew S, Hanley AJ, Connelly PW, Sermer M, Zinman B. Fetal sex and maternal risk of gestational diabetes mellitus: the impact of having a boy. Diabetes Care. 2015;38:844–51.CrossRefPubMed
Metadaten
Titel
Changes in insulin requirements during pregnancy in Japanese women with type 1 diabetes
verfasst von
Misa Kambara
Keiko Yanagisawa
Sayoko Tanaka
Tomoko Suzuki
Tetsuya Babazono
Publikationsdatum
21.08.2018
Verlag
Springer Japan
Erschienen in
Diabetology International / Ausgabe 2/2019
Print ISSN: 2190-1678
Elektronische ISSN: 2190-1686
DOI
https://doi.org/10.1007/s13340-018-0369-8

Weitere Artikel der Ausgabe 2/2019

Diabetology International 2/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.